3 June 2025 in Public Health Nutrition
CCCristina Candal-Pedreira
+4
Objective: Energy drinks (ED) can cause cardiovascular, gastrointestinal and other health disorders. These effects are particularly pronounced in youth. The aim of this study was to systematically review the literature on the consumption of ED in European countries. Design: A systematic bibliographic search was performed in November 2024 in EMBASE, MEDLINE (Ovid), Scopus and Cochrane databases with no restrictions on country, study period, study design and language. Setting: ED are beverages high in caffeine, sugar and other stimulants. Participants: A total of 2008 studies were identified and reviewed by four researchers. Ninety-four met the inclusion criteria and were extracted in a table designed ad hoc. Results: The included studies showed differences regarding their design, definition of consumption and time frame under study. The most studied frequency of ED consumption was weekly consumption, and the most studied population was school students. An increase in the prevalence of consumption was observed when tracking ED consumption over time. Variables most related to consumption were low socio-economic status, alcohol and tobacco consumption, physical activity, age and sex. Conclusions: It is difficult to have a clear picture of the extent of ED consumption in Europe, mainly due to differences in the design of the studies and the lack of periodicity of the estimates in different countries. However, given the health problems that have been associated with ED consumption, regulation of these beverages is essential, especially in youth.
8 March 2025 in Public Health
Energy drinks (ED), which contain high levels of caffeine, are widely popular and their consumption is increasing, especially among young people who may have limited understanding of the associated risks. The aim of this study was to identify the prevalence of ED consumption in North America (Canada, Mexico and the US) and to characterise ED consumers. Systematic review. A systematic review of studies estimating the prevalence of ED consumption was conducted. The characteristics of the studies, populations included, consumption assessment and prevalence of consumption were recorded. Study quality was evaluated using an adaptation of the Newcastle-Ottawa scale. A descriptive analysis of the results was performed. In total, 91 studies conducted in North America were included. All studies were of low to moderate quality. The prevalence of ED consumption was assessed using different temporalities in different studies, which made it impossible to reach a conclusion about the prevalence in North America. Across all populations and temporalities, a considerable range of ED prevalence was observed. It is noteworthy that in studies of university students, weekly ED consumptions >60 % were reported. ED consumption was associated with being male and the co-consumption of alcohol, tobacco and marijuana or cannabis. Results show that ED consumption was highly heterogeneous and widely prevalent, especially among younger populations. This review provides information to help guide and design appropriate public health measures and strategies.
26 November 2024 in Gaceta Sanitaria
CCCristina Candal-Pedreira
+4
To analyze the evolution of hypnosedative use in the Spanish population aged 15 to 64 (2005-2022), identifying regional variations and changes in users profile. We used data from the Survey on the Use of Alcohol and other Drugs in Spain. Past 30-day use was analyzed by sex, age and autonomous community between 2005 and 2022. A multivariate logistic regression was used to identify characteristics of consumption; the temporal trend of prevalence and adjusted odds ratio were evaluated using joinpoint regression models. Between 2005 and 2022, the prevalence of hypnosedative use in Spain increased (from 3.7% to 9.7%) with an annual percentage change of 4.7%. The maximum increase was observed among women aged 55 to 64, reaching a prevalence of 21.4% in 2022. Use increased in all autonomous communities, with Cantabria, La Rioja and Andalusia standing out. The likelihood of using hypnosedatives was higher among women, the oldest age groups, those with basic or intermediate education, those unemployed or economically inactive, those not living with a partner or family, Spanish citizens, and tobacco or cannabis users. An upward trend in the use of hypnosedatives in Spain has been observed since 2005, with variations according to sex, age, and autonomous community. It is crucial to update regional addiction plans, promote preventive strategies and foster collaboration between health authorities, medical professionals and the population to address mental health inequalities and ensure adequate care and responsible prescribing.
9 July 2024 in Gaceta Sanitaria
CCCristina Candal-Pedreira
+2
To assess the perceptions and beliefs of adolescents about cannabis consumption, studying the incentive and disincentive factors for consumption. A systematic review of the literature was carried out following the PRISMA guidelines. MedLine, Embase, APA PsycInfo, Cochrane and Web of Science were searched using controlled vocabulary and free terms. We included qualitative studies published between 2000 and 2024 that assessed the perceptions of adolescents aged 10 to 19 years on the use, effects, risks of using cannabis or cannabis with other legal drugs. The quality of the studies was assessed using the CASP tool. Of the 3665 articles identified in the initial search, 22 complied with elegibility criteria. Data extraction yielded a series of three lines of argument linked to cannabis use: reasons for use, reasons for not using and perceived effects. The most common discourse among adolescents was related to the feeling of social and emotional well-being, fewer adverse effects than drugs, and the influence of peers on consumption. The review preformed reports on the reasons that adolescents allege for cannabis use and reasons for abstention with a view of the preponderance of benefits over harms. It is considered that this information may be necessary for the development of prevention programmes with the dissemination of information on the effects of consumption.
1 January 2025 in Indoor Air
Indoor radon is a human lung carcinogen. The objective of this research is to describe residential radon distribution in a European region with high geogenic radon potential using cross‐sectional data. This study is also aimed at describing the use of census tracts as a geographical unit in radon maps and describing radon distribution according to floor level. To do this, 6080 radon measurements were carried out by the Galician Radon Laboratory (GRL, https://www.radon.gal ) with alpha track detectors located at each dwelling for at least 3 months. The dwellings measured were the primary residences of volunteer participants. All participants filled out a questionnaire on the dwelling characteristics, and a follow‐up call assured the appropriate return of radon devices to the GRL. A descriptive analysis was performed, including radon concentration distribution per floor level measured and a Galician map of indoor radon using both municipalities and census tracts as geographic units was made. In Galicia, a median radon concentration of 132 Bq/m 3 (interquartile range: 66–239 Bq/m 3 ) and a geometric mean (GM) of 126 Bq/m 3 were observed. Eighteen percent of dwellings exceeded 300 Bq/m 3 . Radon levels vary widely across and within municipalities. The latter can be observed with census tract‐level maps. A height gradient for radon concentration was observed from a GM of 289 Bq/m 3 in cellars to a GM of 89 Bq/m 3 on the fifth floor and above. Remarkably, 14% of dwellings on the second floor exceeded 300 Bq/m 3 , thus challenging the paradigm that indoor radon is only a priority for underground and ground levels in radon priority areas. Galicia is mostly composed of radon priority areas, with high heterogeneity in indoor radon distribution. Census tracts can be used in indoor radon maps as the smallest geographic unit to increase resolution and acknowledge variations within municipalities. In radon priority areas, radon surveillance should include second‐floor levels.
22 September 2025 in Revista de Saúde Pública
OBJECTIVE: To characterize retractions of biomedical research papers that had a least one author affiliated with a Latin American (LATAM) institution. METHODS: We conducted a cross-sectional study of research papers published in scientific journals focusing on the field of biomedical research and identified by means of the Retraction Watch database. The retracted articles identified were required to have at least one author whose institutional affiliation was a LATAM country. Data were collected on the authors’ countries and institutional affiliations, the reason for retraction, dates of publication and retraction, indexing, journal quartile and impact factor. Reasons for retraction were categorized into three major groups, i.e., scientific misconduct, error, and not specified. RESULTS: According to Retraction Watch, 181 papers were retracted across 1987–2024 which fulfilled the inclusion criteria. Guatemala, Bolivia, Peru, Panama, Ecuador, Colombia, and Argentina were the countries that had a retraction rate above 1 per 10 thousand papers throughout the study period. The principal reason for retraction was scientific misconduct (63.0%) followed by honest error (21.5%). The main causes of retraction due to scientific misconduct were ethical and legal problems (33.1%), followed by fabrication/falsification (20.2%). CONCLUSION: The number of retractions in some LATAM countries, mainly due to scientific misconduct, highlights the need to strengthen ethical practices in research. Future initiatives should focus on developing and evaluating effective strategies to prevent misconduct and promote scientific integrity.